TADGX | VTSAX | TADGX / VTSAX | |
Total Expense Ratio | 0.89 | 0.04 | 2,225% |
Annual Report Gross Expense Ratio | 0.89 | 0.04 | 2,225% |
Fund Existence | 20 years | 25 years | - |
Gain YTD | 10.062 | 12.375 | 81% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.3B | 1.95T | 1% |
Annual Yield % from dividends | 0.69 | 1.16 | 60% |
Returns for 1 year | 4.34 | 17.19 | 25% |
Returns for 3 years | 35.42 | 67.67 | 52% |
Returns for 5 years | 62.88 | 93.19 | 67% |
Returns for 10 years | 161.43 | 232.21 | 70% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FMNY | 26.68 | 0.10 | +0.38% |
First Trust New York High Inc Mncpl ETF | |||
EALT | 34.33 | 0.07 | +0.20% |
Innovator U.S. Equity 5 To 15 Buf ETF-Qt | |||
PPH | 88.58 | 0.16 | +0.18% |
VanEck Pharmaceutical ETF | |||
RNTY | 50.34 | 0.01 | +0.01% |
Yieldmax Target 12 Real Estate Option Income ETF | |||
SPAB | 25.95 | -0.04 | -0.15% |
SPDR® Portfolio Aggregate Bond ETF |